Literature DB >> 20423098

Drug-like bioactive structures and conformational coverage with the LigPrep/ConfGen suite: comparison to programs MOE and catalyst.

I-Jen Chen1, Nicolas Foloppe.   

Abstract

Computational conformational sampling underpins many aspects of small molecule modeling and design in pharmaceutical work. This work examined in detail the widely distributed LigPrep/ConfGen software suite and the conformational models it produces for drug-like compounds. We also compare LigPrep/ConfGen to MOE and Catalyst. Tests of the conformational sampling protocols included the reproduction of known bioactive structures of ligands, characterization of the size, coverage and diversity of the output conformational models, and relative computation times. The present tests will help the user to make informed choices among the predefined ConfGen protocols (Very fast, Fast, Intermediate, and Comprehensive), and the adjustable input parameters. The parameters governing the initial compound preparation (LigPrep) and the subsequent conformational sampling were explored. This analysis has led to a new protocol called "ConfGen Optimized", which improves upon the predefined protocols. ConfGen Optimized is computationally tractable and reproduced 80% of the bioactive structures within 1 A, versus 66% for the default ConfGen Fast protocol. We also addressed the issue of the reproduction of compact/folded bioactive structures by ConfGen. It involved the compilation of a new set of 50 folded diverse drug-like bioactive structures. This indicates that heuristics penalizing folded conformers hinder reproduction of some binding modes. Overall, ConfGen offers great flexibility of use and provides a valuable addition to the molecular modeling toolbox.

Mesh:

Substances:

Year:  2010        PMID: 20423098     DOI: 10.1021/ci100026x

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  37 in total

1.  Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery-a structure-based approach.

Authors:  Vishwanath Ramatenki; Ramakrishna Dumpati; Rajender Vadija; Santhiprada Vellanki; Sarita Rajender Potlapally; Rohini Rondla; Uma Vuruputuri
Journal:  J Chem Biol       Date:  2016-12-24

2.  Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling.

Authors:  Daniel Cappel; Steven L Dixon; Woody Sherman; Jianxin Duan
Journal:  J Comput Aided Mol Des       Date:  2014-11-19       Impact factor: 3.686

3.  Machine learning on drug-specific data to predict small molecule teratogenicity.

Authors:  Anup P Challa; Andrew L Beam; Min Shen; Tyler Peryea; Robert R Lavieri; Ethan S Lippmann; David M Aronoff
Journal:  Reprod Toxicol       Date:  2020-05-16       Impact factor: 3.143

4.  Ligand binding mode prediction by docking: mdm2/mdmx inhibitors as a case study.

Authors:  Nagakumar Bharatham; Kavitha Bharatham; Anang A Shelat; Donald Bashford
Journal:  J Chem Inf Model       Date:  2014-01-21       Impact factor: 4.956

Review 5.  Recent theoretical and computational advances for modeling protein-ligand binding affinities.

Authors:  Emilio Gallicchio; Ronald M Levy
Journal:  Adv Protein Chem Struct Biol       Date:  2011       Impact factor: 3.507

6.  Structural insights on bioremediation of polycyclic aromatic hydrocarbons using microalgae: a modelling-based computational study.

Authors:  Pandian SureshKumar; Jibu Thomas; Vasudevan Poornima
Journal:  Environ Monit Assess       Date:  2018-01-22       Impact factor: 2.513

7.  Molecular modeling of methyl-α-Neu5Ac analogues docked against cholera toxin--a molecular dynamics study.

Authors:  J Jino Blessy; D Jeya Sundara Sharmila
Journal:  Glycoconj J       Date:  2015-02-13       Impact factor: 2.916

8.  Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions.

Authors:  Ramin Ekhteiari Salmas; Mine Yurtsever; Matthias Stein; Serdar Durdagi
Journal:  Mol Divers       Date:  2015-02-05       Impact factor: 2.943

9.  Homology modeling and virtual screening studies of FGF-7 protein-a structure-based approach to design new molecules against tumor angiogenesis.

Authors:  Rajender Vadija; Kiran Kumar Mustyala; Navaneetha Nambigari; Ramasree Dulapalli; Rama Krishna Dumpati; Vishwanath Ramatenki; Santhi Prada Vellanki; Uma Vuruputuri
Journal:  J Chem Biol       Date:  2016-06-18

10.  The role of ZA channel water-mediated interactions in the design of bromodomain-selective BET inhibitors.

Authors:  Nagakumar Bharatham; Peter J Slavish; William R Shadrick; Brandon M Young; Anang A Shelat
Journal:  J Mol Graph Model       Date:  2018-03-22       Impact factor: 2.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.